This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Simon Crumpler: Innovator in KDM5 Inhibitory Compounds
Introduction
Simon Crumpler is a notable inventor based in Saffron Walden, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that exhibit KDM5 inhibitory activity. His work is crucial in the fight against various diseases, including cancer, Huntington's disease, and Alzheimer's disease.
Latest Patents
Crumpler holds a patent for a compound having KDM5 inhibitory activity and its pharmaceutical use. The compound is represented by a specific general formula, where all symbols have defined meanings as described in the specification. This compound is recognized for its potential as a prophylactic and therapeutic agent for serious health conditions.
Career Highlights
Simon Crumpler is associated with Ono Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in the pharmaceutical sector. His innovative approach and dedication to his work have positioned him as a key figure in his field.
Collaborations
Crumpler has collaborated with esteemed colleagues such as Shuhei Umemura and Hidenori Takahashi. Their combined expertise has contributed to the successful development of groundbreaking pharmaceutical solutions.
Conclusion
In summary, Simon Crumpler is a distinguished inventor whose work in KDM5 inhibitory compounds holds promise for treating critical diseases. His contributions to the pharmaceutical industry are invaluable and continue to pave the way for future innovations.